Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 138th ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
CAPS	CAPSTONE HOLDING CORP	$1.28	0.00%	10.34%	3.23%	-32.28%	-57.05%	N/A	N/A	N/A	N/A	$4.18	$0.97	69.38%	31.82%	1.55	96,000	-38.46%
NRXS	NEURAXIS INC	$2.34	-3.31%	-3.31%	-2.90%	-7.14%	9.86%	-25.71%	N/A	N/A	N/A	$6.20	$1.33	62.26%	75.94%	0.97	36,400	180.00%
NERV	MINERVA NEUROSCIENCES INC	$2.25	3.21%	3.69%	0.00%	26.40%	44.23%	-23.08%	-75.17%	-91.48%	-95.07%	$2.98	$1.15	24.50%	95.65%	0.47	38,500	253.21%
NBY	NOVABAY PHARMACEUTICALS INC	$2.74	5.79%	1.48%	343.37%	356.67%	325.47%	460.33%	-98.49%	-99.72%	-99.98%	$4.44	$0.46	38.29%	495.65%	0.53	2,457,000	66.58%
NAUT	NAUTILUS BIOTECHNOLOGY INC	$0.77	7.35%	10.41%	8.56%	7.50%	-30.89%	-73.85%	-64.98%	-92.90%	N/A	$3.09	$0.62	74.95%	24.84%	1.55	359,000	25.09%
MTNB	MATINAS BIOPHARMA HOLDINGS INC	$1.75	-4.37%	4.79%	-25.85%	87.97%	221.10%	-52.83%	-95.07%	-95.48%	N/A	$4.25	$0.48	58.82%	268.42%	1.01	28,200	-41.25%
DYAI	DYADIC INTERNATIONAL INC	$0.97	-0.10%	0.10%	29.14%	3.87%	-31.00%	-21.46%	-59.24%	-87.47%	N/A	$2.20	$0.71	56.09%	35.86%	0.80	72,000	51.26%
ADXN	ADDEX THERAPEUTICS LTD	$9.62	-10.09%	24.13%	21.16%	14.76%	24.94%	-4.75%	-49.90%	-95.92%	N/A	$12.05	$6.51	20.17%	47.77%	0.43	42,000	-94.62%
ANEB	ANEBULO PHARMACEUTICALS INC	$2.46	3.80%	11.82%	-1.60%	55.70%	57.69%	17.70%	-35.43%	N/A	N/A	$3.42	$0.80	28.07%	207.50%	0.52	110,000	-89.08%
AKTX	AKARI THERAPEUTICS PLC	$0.78	-1.77%	-8.82%	-23.27%	-28.90%	-29.55%	-76.30%	-94.30%	-97.73%	-99.81%	$3.85	$0.57	79.87%	35.73%	0.40	15,000	-41.63%
MLEC	MOOLEC SCIENCE SA	$1.33	-3.62%	17.70%	-45.96%	-81.27%	-84.20%	-85.69%	-98.68%	N/A	N/A	$10.47	$1.10	87.30%	20.91%	0.38	16,600	-86.72%
KLRS	KALARIS THERAPEUTICS INC	$3.71	-4.63%	-20.04%	50.81%	38.95%	-61.59%	-78.78%	-98.08%	-99.23%	N/A	$24.15	$2.14	84.64%	73.36%	1.45	167,000	-21.96%
ABP	ABPRO HOLDINGS INC	$0.18	4.60%	-14.15%	-31.58%	-19.82%	-63.31%	-98.41%	-98.18%	N/A	N/A	$13.00	$0.15	98.60%	19.74%	0.41	2,359,000	1,787.20%
QLGN	QUALIGEN THERAPEUTICS INC	$2.03	-3.10%	17.34%	6.84%	-43.53%	-34.52%	-76.22%	-98.76%	-99.91%	-100.00%	$10.45	$1.61	80.57%	26.09%	0.62	28,500	14.00%
EPRX	EUPRAXIA PHARMACEUTICALS INC	$5.30	-0.28%	0.57%	-0.43%	27.10%	26.79%	107.03%	N/A	N/A	N/A	$6.20	$2.20	14.52%	140.91%	0.54	4,300	-23.21%
LSB	LAKESHORE BIOPHARMA CO LTD	$0.81	-3.13%	-3.59%	3.21%	-19.50%	-61.85%	-88.80%	-99.18%	N/A	N/A	$8.60	$0.59	90.64%	36.44%	0.25	25,300	-50.10%
LPCN	LIPOCINE INC	$2.97	-0.17%	2.06%	-1.88%	-2.94%	-15.14%	-37.47%	-69.97%	-87.95%	-98.97%	$6.17	$2.68	51.85%	10.66%	0.79	7,700	-40.31%
LEXX	LEXARIA BIOSCIENCE CORP	$1.30	9.24%	25.00%	58.54%	28.71%	-11.38%	-61.42%	-55.63%	-83.95%	-74.95%	$3.41	$0.78	61.88%	67.74%	0.78	206,000	-41.31%
ANL	ADLAI NORTYE LTD	$1.79	0.28%	5.29%	5.92%	2.87%	-20.44%	-20.44%	N/A	N/A	N/A	$3.89	$1.10	53.98%	62.73%	0.63	12,700	78.87%
APLM	APOLLOMICS INC	$9.29	36.02%	71.18%	63.84%	43.50%	16.56%	-31.13%	-99.08%	N/A	N/A	$35.98	$3.66	74.18%	153.89%	0.14	233,000	540.11%
KZR	KEZAR LIFE SCIENCES INC	$3.91	-1.01%	-2.49%	-1.51%	-9.91%	-33.39%	-31.76%	-96.02%	-92.04%	N/A	$9.18	$3.62	57.41%	8.01%	0.97	12,600	240.54%
KPRX	KIORA PHARMACEUTICALS INC	$2.61	-1.14%	-2.87%	-10.92%	-13.29%	-20.67%	-23.46%	-96.78%	-99.81%	-99.99%	$4.18	$2.27	37.56%	14.98%	0.86	11,000	-53.59%
MTVA	METAVIA INC	$1.50	115.52%	117.39%	134.38%	105.76%	-5.66%	-56.40%	-99.24%	-99.90%	N/A	$3.72	$0.56	59.68%	170.27%	0.44	85,919,000	296,172.41%
IVA	INVENTIVA SA	$5.31	-5.35%	-1.12%	21.79%	57.94%	86.32%	140.27%	36.08%	-53.01%	N/A	$6.50	$1.53	18.31%	247.06%	0.30	27,500	-78.52%
INDP	INDAPTUS THERAPEUTICS INC	$2.28	-11.63%	-21.65%	-67.98%	-73.90%	-89.98%	-94.78%	-96.96%	-99.65%	-99.98%	$58.24	$2.22	96.09%	2.70%	1.11	237,000	-87.80%
ADAP	ADAPTIMMUNE THERAPEUTICS PLC	$0.07	19.64%	55.81%	13.56%	-73.62%	-85.34%	-93.62%	-95.86%	-99.34%	-99.47%	$1.09	$0.04	93.85%	67.50%	1.23	93,327,000	40.50%
IMA	IMAGENEBIO INC	$8.96	-1.97%	-3.55%	-36.90%	-47.04%	-43.00%	-56.59%	-83.26%	N/A	N/A	$23.28	$7.95	61.51%	12.70%	1.02	21,300	-61.27%
IGC	IGC PHARMA INC	$0.42	3.17%	1.93%	14.32%	41.95%	32.19%	20.51%	-22.10%	-65.61%	113.64%	$0.50	$0.25	15.06%	67.19%	0.86	595,000	14.42%
ATHA	ATHIRA PHARMA INC	$0.38	6.67%	-0.26%	-4.24%	20.00%	17.43%	-24.11%	-89.24%	-97.76%	N/A	$0.83	$0.22	53.51%	74.55%	1.26	295,000	-57.86%
LPTX	LEAP THERAPEUTICS INC	$0.31	3.34%	8.04%	15.30%	-21.17%	-27.29%	-89.73%	-97.38%	-98.38%	N/A	$4.79	$0.22	93.55%	39.19%	1.33	647,000	6.77%
GDTC	CYTOMED THERAPEUTICS LTD	$2.13	-6.17%	16.39%	18.33%	2.40%	-19.62%	42.00%	N/A	N/A	N/A	$4.05	$1.20	47.41%	77.50%	0.68	10,400	-83.90%
INM	INMED PHARMACEUTICALS INC	$2.22	3.74%	3.26%	-4.31%	-6.33%	-18.98%	-55.88%	-98.84%	N/A	N/A	$8.27	$1.72	73.16%	29.07%	1.19	118,000	28.26%
HLVX	HILLEVAX INC	$2.10	0.48%	0.48%	0.96%	12.90%	18.64%	17.32%	-90.02%	N/A	N/A	$2.17	$1.34	3.23%	56.72%	1.08	539,000	-56.57%
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	$1.05	-4.55%	-13.58%	-15.32%	15.38%	0.96%	-16.67%	-69.91%	N/A	N/A	$2.92	$0.64	64.04%	64.06%	0.86	61,000	-62.35%
BBOT	BRIDGEBIO ONCOLOGY THERAPEUTICS INC	$9.73	-6.35%	-11.63%	-8.64%	-10.07%	-9.49%	-6.44%	N/A	N/A	N/A	$12.50	$8.50	22.16%	14.47%	0.01	183,000	-5.67%
ENSC	ENSYSCE BIOSCIENCES INC	$2.07	-1.90%	-1.43%	0.98%	-3.72%	-46.92%	-60.00%	-99.83%	-99.99%	N/A	$14.67	$1.62	85.89%	27.78%	0.99	98,000	157.89%
GNTA	GENENTA SCIENCE SPA	$3.01	2.03%	-12.50%	-14.12%	-14.73%	-22.72%	-15.45%	-42.60%	N/A	N/A	$7.28	$2.56	58.65%	17.58%	0.33	4,100	-82.63%
GNFT	GENFIT SA	$4.33	2.00%	9.42%	8.60%	4.41%	19.04%	4.79%	4.66%	-7.81%	N/A	$6.42	$2.55	32.54%	69.92%	0.26	3,900	11.43%
IPSC	CENTURY THERAPEUTICS INC	$0.50	-0.80%	-2.55%	-11.57%	-14.75%	-20.48%	-68.74%	-95.27%	N/A	N/A	$1.86	$0.34	73.28%	45.32%	1.27	273,000	-11.94%
IMRN	IMMURON LTD	$1.86	-3.63%	-1.06%	2.76%	4.49%	2.25%	-30.60%	-15.95%	-78.12%	N/A	$2.87	$1.50	35.12%	24.00%	0.77	49,700	17.22%
LSTA	LISATA THERAPEUTICS INC	$2.12	-3.20%	-2.75%	-16.21%	-15.54%	-10.92%	-27.15%	-66.08%	-92.68%	-99.24%	$4.20	$1.87	49.52%	13.37%	0.78	11,300	113.21%
EXOZ	EXOZYMES INC	$13.49	8.79%	12.42%	39.07%	6.30%	-5.00%	N/A	N/A	N/A	N/A	$23.99	$8.50	43.77%	58.71%	0.41	1,200	N/A
EVGN	EVOGENE LTD	$1.24	-2.68%	-2.68%	-8.44%	-18.68%	-14.17%	-58.80%	-87.88%	-95.37%	-98.59%	$3.32	$0.95	62.77%	30.11%	0.99	48,600	116.00%
ERNA	ERNEXA THERAPEUTICS INC	$1.18	-8.53%	-4.84%	-25.79%	-50.63%	-71.29%	-94.79%	-98.84%	-99.88%	-99.98%	$22.35	$1.17	94.72%	0.85%	1.19	191,000	6.11%
ENTX	ENTERA BIO LTD	$1.83	1.67%	-8.50%	-8.50%	-8.50%	-6.15%	-8.96%	37.59%	64.86%	N/A	$2.79	$1.50	34.41%	21.92%	0.59	125,000	23.76%
BOLT	BOLT BIOTHERAPEUTICS INC	$5.32	2.72%	3.30%	3.30%	-7.80%	-35.14%	-58.73%	-85.30%	N/A	N/A	$14.36	$4.59	62.95%	15.90%	0.89	11,600	213.51%
ESLA	ESTRELLA IMMUNOPHARMA INC	$1.05	0.38%	5.40%	15.82%	10.95%	10.14%	8.66%	-89.51%	N/A	N/A	$1.78	$0.63	40.79%	67.30%	0.23	24,000	70.21%
DWTX	DOGWOOD THERAPEUTICS INC	$4.87	-0.41%	-0.61%	-1.22%	1.67%	-20.03%	-0.81%	-97.49%	N/A	N/A	$29.28	$1.62	83.37%	200.62%	0.82	8,600	-50.86%
ENVB	ENVERIC BIOSCIENCES INC	$0.94	-3.09%	4.56%	-14.55%	-25.98%	-46.29%	-87.49%	-98.91%	-99.97%	N/A	$8.33	$0.85	88.71%	10.59%	1.55	56,000	-56.25%
ELAB	PMGC HOLDINGS INC	$5.77	20.71%	30.84%	-14.58%	-19.97%	-61.07%	-99.62%	N/A	N/A	N/A	$1.81k	$4.29	99.68%	34.66%	1.20	212,000	495.51%
EDSA	EDESA BIOTECH INC	$2.40	0.00%	-0.83%	7.14%	16.50%	-1.64%	-43.02%	-80.52%	-95.12%	N/A	$5.00	$1.55	52.00%	54.84%	0.86	3,500	-12.50%
DRTS	ALPHA TAU MEDICAL LTD	$3.85	1.05%	4.34%	17.38%	28.46%	44.74%	68.12%	-31.00%	N/A	N/A	$4.39	$2.11	12.24%	82.46%	0.36	41,000	115.79%
CMMB	CHEMOMAB THERAPEUTICS LTD	$2.82	-6.99%	-7.39%	-24.19%	-42.68%	-53.00%	-59.37%	-78.44%	-95.88%	N/A	$9.84	$2.70	71.34%	4.44%	1.10	140,000	495.74%
DRMA	DERMATA THERAPEUTICS INC	$5.43	0.46%	3.23%	-9.20%	-22.43%	-53.59%	-76.59%	-99.65%	N/A	N/A	$23.80	$5.04	77.18%	7.72%	0.50	117,000	415.42%
CYCN	CYCLERION THERAPEUTICS INC	$2.36	-4.07%	4.42%	0.21%	-23.50%	-7.45%	-21.33%	-87.17%	-98.42%	N/A	$9.47	$1.27	75.08%	85.83%	1.06	18,300	-24.69%
CNTX	CONTEXT THERAPEUTICS INC	$0.81	-2.75%	-1.10%	3.31%	33.11%	-3.56%	-60.96%	-49.88%	N/A	N/A	$2.59	$0.49	68.65%	65.71%	0.96	66,500	43.32%
CUE	CUE BIOPHARMA INC	$0.74	-0.27%	-4.76%	-10.41%	25.42%	-22.11%	31.44%	-77.37%	-95.89%	N/A	$1.99	$0.45	62.80%	64.44%	1.35	120,000	-66.94%
MURA	MURAL ONCOLOGY PLC	$2.07	-0.48%	0.00%	17.61%	-15.51%	-49.14%	-36.11%	N/A	N/A	N/A	$4.74	$0.95	56.33%	117.89%	0.77	97,000	16.17%
CRIS	CURIS INC	$1.70	-6.59%	-0.58%	-7.10%	-31.17%	-42.37%	-71.04%	-90.65%	-92.41%	-99.31%	$6.44	$1.02	73.60%	66.67%	0.89	111,000	37.04%
INTS	INTENSITY THERAPEUTICS INC	$0.24	1.72%	-18.90%	-20.00%	-22.37%	-89.46%	-94.20%	N/A	N/A	N/A	$4.19	$0.19	94.36%	27.57%	0.25	7,995,000	331.23%
BRTX	BIORESTORATIVE THERAPIES INC	$1.51	-1.95%	-6.21%	-0.66%	-6.79%	-9.58%	-16.11%	-51.31%	-98.18%	-99.99%	$2.55	$1.21	40.78%	24.79%	0.66	50,000	-29.08%
COCP	COCRYSTAL PHARMA INC	$1.43	-9.49%	-4.67%	-15.63%	-2.05%	-13.91%	-17.58%	-66.90%	-87.46%	N/A	$3.26	$1.12	56.13%	27.68%	0.65	1,918,000	-97.69%
CNSP	CNS PHARMACEUTICALS INC	$9.20	24.49%	43.97%	80.75%	-5.47%	-74.95%	-89.90%	-100.00%	-100.00%	N/A	$221.94	$4.93	95.85%	86.61%	0.73	94,000	168.57%
THTX	THERATECHNOLOGIES INC	$3.29	-0.30%	0.61%	1.54%	35.95%	104.35%	131.69%	-63.93%	-64.85%	-49.23%	$3.31	$1.12	0.60%	193.75%	0.74	269,000	-61.41%
ENTO	ENTERO THERAPEUTICS INC	$3.59	13.97%	36.50%	96.17%	139.33%	124.52%	226.96%	-99.58%	-100.00%	N/A	$3.70	$0.93	2.97%	286.02%	0.54	326,000	-46.99%
CMND	CLEARMIND MEDICINE INC	$1.03	0.59%	1.58%	-0.39%	17.93%	-10.00%	-22.86%	N/A	N/A	N/A	$2.18	$0.80	52.94%	28.25%	0.27	37,400	73.95%
CLGN	COLLPLANT BIOTECHNOLOGIES LTD	$2.63	0.38%	-0.38%	3.14%	59.39%	-17.30%	-47.40%	-67.10%	-70.55%	N/A	$5.00	$1.31	47.40%	100.76%	0.47	3,600	-85.06%
CLLS	CELLECTIS SA	$2.99	3.46%	9.12%	4.91%	115.88%	144.08%	30.00%	-6.27%	-85.18%	-91.06%	$3.35	$1.10	10.75%	171.82%	1.44	96,000	-36.00%
CELZ	CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC	$3.48	-0.57%	5.45%	11.54%	62.62%	8.41%	2.53%	-49.57%	-78.91%	N/A	$6.90	$1.69	49.57%	105.92%	0.62	30,600	25.93%
ICCC	IMMUCELL CORP	$5.95	0.51%	-9.23%	-2.51%	-6.30%	19.72%	66.20%	-21.40%	13.55%	-9.71%	$7.60	$3.34	21.71%	78.14%	0.24	40,000	488.24%
GNPX	GENPREX INC	$0.28	-5.82%	33.50%	29.72%	-10.71%	-31.25%	-29.67%	-99.59%	-99.82%	N/A	$3.97	$0.14	93.07%	96.43%	1.19	2,913,000	-76.66%
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	$3.75	-1.06%	3.31%	3.31%	-5.06%	-72.99%	-53.89%	-98.75%	N/A	N/A	$53.10	$3.22	92.94%	16.46%	0.87	8,100	-47.40%
CASI	CASI PHARMACEUTICALS INC	$2.09	-8.33%	-11.06%	-12.18%	57.14%	-7.52%	-69.67%	-50.59%	-87.71%	-77.03%	$7.50	$1.09	72.13%	91.57%	0.78	35,700	-7.27%
CARM	CARISMA THERAPEUTICS INC	$0.35	-7.49%	-12.85%	18.49%	-19.53%	-16.43%	-65.74%	-97.42%	-98.40%	-99.43%	$1.27	$0.14	72.76%	143.66%	1.28	961,000	21.03%
IPHA	INNATE PHARMA SA	$2.08	3.80%	1.76%	-5.21%	11.02%	2.77%	-4.33%	-18.27%	-52.28%	N/A	$3.51	$1.29	40.87%	60.93%	0.59	10,000	-45.36%
CANF	CAN-FITE BIOPHARMA LTD	$0.65	-2.12%	-1.37%	-2.42%	-43.33%	-60.85%	-72.63%	-92.90%	-96.58%	-99.75%	$3.12	$0.63	79.29%	2.54%	0.56	678,000	816.22%
CAMP	CAMP4 THERAPEUTICS CORP	$2.65	-18.46%	60.61%	58.68%	82.76%	-50.65%	N/A	N/A	N/A	N/A	$12.30	$1.31	78.46%	103.07%	1.22	536,000	-58.16%
EPIX	ESSA PHARMA INC	$0.19	-5.42%	-18.99%	-90.05%	-88.71%	-88.00%	-97.26%	-91.43%	-97.54%	-99.85%	$7.41	$0.19	97.41%	2.67%	0.78	2,182,000	26.49%
IMMP	IMMUTEP LTD	$1.73	5.49%	0.58%	0.00%	1.17%	-4.95%	-25.11%	-7.49%	7.45%	-55.64%	$2.71	$1.32	36.16%	31.06%	0.97	94,000	186.59%
CALC	CALCIMEDICA INC	$2.85	-10.09%	-7.77%	-2.06%	67.65%	39.02%	-29.98%	-81.49%	N/A	N/A	$5.65	$1.42	49.56%	100.70%	0.42	225,000	227.99%
ORMP	ORAMED PHARMACEUTICALS INC	$2.32	-3.73%	0.87%	11.54%	7.41%	-2.11%	-6.45%	-72.45%	-21.36%	-58.79%	$3.09	$1.82	24.92%	27.47%	1.18	106,000	2.91%
LVTX	LAVA THERAPEUTICS NV	$1.54	-0.32%	-0.65%	1.32%	19.38%	17.56%	-10.26%	-34.19%	N/A	N/A	$2.09	$0.85	26.42%	81.18%	0.34	53,000	-7.02%
BYSI	BEYONDSPRING INC	$1.87	2.75%	-1.58%	-7.43%	-37.67%	6.86%	-14.22%	28.08%	-87.39%	N/A	$3.44	$0.98	45.64%	90.82%	0.86	30,000	209.28%
GLTO	GALECTO INC	$2.83	-1.39%	-8.41%	-16.27%	-14.63%	-30.64%	-77.82%	-95.36%	N/A	N/A	$14.56	$2.01	80.56%	40.80%	1.25	109,000	0.93%
KTTA	PASITHEA THERAPEUTICS CORP	$0.77	-0.26%	-0.13%	9.39%	-0.77%	-31.95%	-80.38%	-96.80%	N/A	N/A	$7.50	$0.65	89.75%	18.31%	0.25	49,300	-6.27%
BOLD	BOUNDLESS BIO INC	$1.15	0.00%	0.00%	-0.86%	5.50%	-31.55%	-69.50%	N/A	N/A	N/A	$4.72	$1.00	75.64%	15.00%	1.38	67,000	-42.74%
BLRX	BIOLINERX LTD	$3.75	-7.18%	3.02%	1.08%	-19.70%	16.46%	-85.35%	-94.10%	-94.61%	-99.63%	$26.80	$2.30	86.01%	63.04%	0.84	43,400	161.45%
BHST	BIOHARVEST SCIENCES INC	$9.08	3.09%	27.20%	-2.60%	32.78%	52.90%	N/A	N/A	N/A	N/A	$9.90	$4.72	8.24%	92.25%	0.55	64,000	-68.32%
MOLN	MOLECULAR PARTNERS AG	$3.75	0.67%	4.61%	7.93%	-2.47%	-12.50%	-28.12%	-40.65%	N/A	N/A	$7.60	$3.36	50.72%	11.46%	0.53	1,100	-52.17%
MBRX	MOLECULIN BIOTECH INC	$0.37	2.20%	-4.37%	-45.45%	-45.69%	-67.08%	-84.56%	-98.25%	-99.49%	N/A	$3.65	$0.25	89.81%	48.80%	0.85	1,555,000	-39.00%
BCDA	BIOCARDIA INC	$2.15	0.47%	2.87%	11.98%	-6.52%	-17.94%	-23.76%	-92.94%	-93.96%	-98.34%	$3.25	$1.63	33.85%	32.31%	0.82	50,300	-2.14%
APLT	APPLIED THERAPEUTICS INC	$0.42	-1.19%	-5.45%	-13.15%	12.43%	-23.81%	-91.13%	-71.89%	-98.26%	N/A	$10.62	$0.30	96.08%	41.02%	1.06	783,000	-4.04%
ARMP	ARMATA PHARMACEUTICALS INC	$2.99	1.70%	6.03%	17.25%	62.50%	46.57%	37.16%	-6.85%	-17.40%	-99.70%	$3.14	$0.90	4.78%	232.96%	0.39	2,300	-61.67%
MNOV	MEDICINOVA INC	$1.24	0.81%	-1.59%	-5.34%	-6.77%	-19.48%	-31.11%	-43.64%	-78.69%	-60.51%	$2.55	$1.13	51.37%	9.73%	0.73	19,000	-8.21%
APRE	APREA THERAPEUTICS INC	$1.51	-2.20%	-6.21%	-10.65%	-14.69%	-35.47%	-51.05%	-91.45%	-99.74%	N/A	$5.01	$1.41	69.86%	6.94%	0.60	51,000	21.43%
APM	APTORUM GROUP LTD	$1.96	-1.01%	14.62%	41.01%	73.45%	107.85%	-31.23%	-87.19%	-87.59%	N/A	$7.49	$0.46	73.83%	326.09%	0.48	157,000	-43.12%
PPBT	PURPLE BIOTECH LTD	$0.57	-1.05%	-5.68%	-75.54%	-77.22%	-79.82%	-92.96%	-98.68%	-99.35%	N/A	$13.95	$0.53	95.95%	6.00%	0.69	427,000	-14.60%
ANTX	AN2 THERAPEUTICS INC	$1.24	-3.13%	4.20%	15.89%	14.81%	-10.79%	18.10%	-85.41%	N/A	N/A	$1.68	$0.98	25.97%	27.18%	0.84	92,000	-5.15%
AIM	AIM IMMUNOTECH INC	$2.55	-1.92%	-1.54%	-3.77%	-73.16%	2,025.00%	758.59%	286.36%	28.79%	-97.29%	$20.35	$0.06	87.47%	3,947.62%	109.01	37,000	19.35%
ADAG	ADAGENE INC	$2.11	-5.80%	-11.72%	24.85%	9.33%	16.57%	-23.27%	48.59%	N/A	N/A	$3.16	$1.33	33.23%	59.25%	0.31	36,800	-62.45%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Sep 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Theravance Biopharma (NASDAQ:TBPH)

Theravance Biopharma (NASDAQ:TBPH) is the #1 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Theravance Biopharma (NASDAQ:TBPH) is: Value: B, Growth: A, Momentum: C, Sentiment: B, Safety: D, Financials: A, and AI: C.

Theravance Biopharma (NASDAQ:TBPH) has a Due Diligence Score of 39, which is 16 points higher than the biotech industry average of 23.

TBPH passed 12 out of 33 due diligence checks and has average fundamentals. Theravance Biopharma has seen its stock return 77.34% over the past year, overperforming other biotech stocks by 127 percentage points.

Theravance Biopharma has an average 1 year price target of $25.67, an upside of 78.24% from Theravance Biopharma's current stock price of $14.40.

Theravance Biopharma stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Theravance Biopharma, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 40, which is 17 points higher than the biotech industry average of 23.

RIGL passed 13 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 171.27% over the past year, overperforming other biotech stocks by 221 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $32.00, a downside of -14.21% from Rigel Pharmaceuticals's current stock price of $37.30.

Rigel Pharmaceuticals stock has a consensus Hold recommendation according to Wall Street analysts. Of the 1 analyst covering Rigel Pharmaceuticals, 0% have issued a Strong Buy rating, 0% have issued a Buy, 100% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

Biocryst Pharmaceuticals (NASDAQ:BCRX) is the #3 top biotech stock out of 637 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Biocryst Pharmaceuticals (NASDAQ:BCRX) is: Value: B, Growth: A, Momentum: D, Sentiment: A, Safety: C, Financials: B, and AI: B.

Biocryst Pharmaceuticals (NASDAQ:BCRX) has a Due Diligence Score of 12, which is -11 points lower than the biotech industry average of 23. Although this number is below the industry average, our proven quant model rates BCRX as a "A".

BCRX passed 4 out of 33 due diligence checks and has weak fundamentals. Biocryst Pharmaceuticals has seen its stock lose -2.65% over the past year, overperforming other biotech stocks by 47 percentage points.

Biocryst Pharmaceuticals has an average 1 year price target of $17.13, an upside of 122.4% from Biocryst Pharmaceuticals's current stock price of $7.70.

Biocryst Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Biocryst Pharmaceuticals, 37.5% have issued a Strong Buy rating, 50% have issued a Buy, 12.5% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 6 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Essa Pharma (NASDAQ:EPIX)

Essa Pharma (NASDAQ:EPIX) has an annual dividend yield of 880.74%, which is 753 percentage points higher than the biotech industry average of 127.91%.

Essa Pharma's dividend payout ratio of 0% indicates that its high dividend yield might not be sustainable for the long-term.

2. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 9.11%, which is -119 percentage points lower than the biotech industry average of 127.91%.

Dominari Holdings's dividend payout ratio of -13.4% indicates that its high dividend yield might not be sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 2.48%, which is -125 percentage points lower than the biotech industry average of 127.91%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 37.2% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -0.46% in the last day, and down -1.01% over the last week. Atyr Pharma was the among the top losers in the biotechnology industry, dropping -83.17% yesterday.

aTyr Pharma shares are trading lower after the company announced topline results from its Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has dropped -16.15% in the past year. It has overperformed other stocks in the biotech industry by 34 percentage points.

2. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has gained 84.13% in the past year. It has overperformed other stocks in the biotech industry by 134 percentage points.

3. Incyte (NASDAQ:INCY)

Incyte (NASDAQ:INCY) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Incyte has a valuation score of 86, which is 72 points higher than the biotech industry average of 14. It passed 6 out of 7 valuation due diligence checks.

Incyte's stock has gained 25.19% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

Are biotech stocks a good buy now?

55.4% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 81.39% over the next year.

2.11% of biotech stocks have a Zen Rating of A (Strong Buy), 4.43% of biotech stocks are rated B (Buy), 41.98% are rated C (Hold), 35.44% are rated D (Sell), and 16.03% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -100.7x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Theravance Biopharma (NASDAQ:TBPH)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Biocryst Pharmaceuticals (NASDAQ:BCRX)

1. Essa Pharma (NASDAQ:EPIX)

2. Dominari Holdings (NASDAQ:DOMH)

3. Royalty Pharma (NASDAQ:RPRX)

1. Harmony Biosciences Holdings (NASDAQ:HRMY)

2. Puma Biotechnology (NASDAQ:PBYI)

3. Incyte (NASDAQ:INCY)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.